Stock Research: Penumbra

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Penumbra

NYSE:PEN US70975L1070
90
  • Value
    95
  • Growth
    75
  • Safety
    Safety
    1
  • Combined
    64
  • Sentiment
    96
  • 360° View
    360° View
    90
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Penumbra, Inc. is a thrombectomy company focused on developing technologies for challenging medical conditions by removing blood clots. Its main businesses include developing, manufacturing, and marketing novel products for conditions such as ischemic stroke, venous thromboembolism, acute limb ischemia, and acute coronary syndrome. The company operates in the United States, Europe, Canada, and Australia. In the last fiscal year, the company had 4500 employees, a market cap of $9155 million, profits of $755 million, and revenue of $1195 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 90 (better than 90% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Penumbra are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Penumbra. The consolidated Growth Rank has a good rank of 75, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 75% of competitors in the same industry. The consolidated Safety Rank at 95 means that the company has a financing structure that is safer than 95% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 1, meaning that the share price of Penumbra is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 99% of alternative stocks in the same industry. ...read more

more
Index
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
1 7 8 11
Growth
75 77 89 81
Safety
Safety
95 98 85 85
Sentiment
96 79 87 84
360° View
360° View
90 91 70 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
85 69 55 88
Opinions Change
50 21 50 75
Pro Holdings
n/a 75 60 10
Market Pulse
93 95 97 87
Sentiment
96 79 87 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
1 7 8 11
Growth
75 77 89 81
Safety Safety
95 98 85 85
Combined
64 81 57 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
8 15 20 12
Price vs. Earnings (P/E)
13 16 17 28
Price vs. Book (P/B)
1 27 26 28
Dividend Yield
1 1 1 1
Value
1 7 8 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
75 61 62 43
Profit Growth
90 94 100 100
Capital Growth
5 45 48 63
Stock Returns
73 59 79 71
Growth
75 77 89 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
84 82 68 77
Refinancing
29 22 7 11
Liquidity
95 98 13 13
Safety Safety
95 98 85 85

Similar Stocks

Discover high‑ranked alternatives to Penumbra and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

Spectrum Brands

NYSE:SPB
Country: USA
Industry: Household Products
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.